It’s definitely dark and maybe even disturbing, but a book I have always enjoyed is Thomas Harris’ “The Silence of the Lambs.” If you’re unfamiliar with either the book or the movie, you’ve either been living a sheltered life or you need to find someone whose birth year starts with “1” to tell you about…
UC Davis Health named Center for Comprehensive MS Care
The National Multiple Sclerosis Society has designated UC Davis Health in California as a new Center for Comprehensive MS Care, recognizing its ability to provide coordinated, multidisciplinary care for people with multiple sclerosis (MS). The designation is part of the society’s Network of MS Healthcare Professionals, which highlights centers that meet specific standards for comprehensive…
In life with relapsing-remitting MS, I am my own best advocate
In recognition of Multiple Sclerosis Awareness Month in March, the MS Awareness Month campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like this, using the hashtag #MSAwarenessMonth, or read the full series….
Trial of novel autoimmune disease treatment ICP-538 launches in China
Innocare Pharma has dosed the first healthy volunteer in a clinical trial in China testing ICP-538, its oral treatment candidate for multiple sclerosis (MS) and other autoimmune diseases. The novel experimental therapy works by promoting the degradation of the VAV1 protein, essential for the function of T-cells and B-cells, which are immune cells that play…
Late-onset MS linked to faster disability progression: Study
People with multiple sclerosis (MS) who experience their first symptoms after age 50 tend to have faster disability progression than those with earlier disease onset, according to a recent study. The also more commonly develop primary progressive MS (PPMS). In addition, late-onset MS was associated with a higher risk of reaching certain disability milestones and faster transition…
The lived reality of MS is more than the disease’s clinical definition
Multiple sclerosis (MS) is a chronic neurological condition wherein the immune system attacks the protective covering of nerves. This clinical definition accurately portrays the medical reality, but it doesn’t encapsulate the lived reality. It doesn’t account for the ways in which fatigue can feel like gravity doubling overnight with no warning, how cognitive fog can…
Using Your Voice
By Angel Blair It can be a truly powerful thing. Yes, sometimes it’s not easy. It can make you feel uncomfortable, unsure, and anxious. But eventually you find that it is absolutely necessary in order to take care of yourself … Continue reading → Source: blog.mymsaa.org
I’m still learning acceptance in life with MS, but I always show up
In recognition of Multiple Sclerosis Awareness Month in March, the MS Awareness Month campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like this, using the hashtag #MSAwarenessMonth, or read the full series….
Stopping Ocrevus in stable MS doesn’t seem to raise 2-year risk, study finds
For people with multiple sclerosis (MS) on Ocrevus (ocrelizumab) whose disease is well controlled after at least a year of treatment, discontinuing the infusion therapy does not appear to increase the risk of new disease activity or disability progression for about two years. That’s according to a new retrospective study from Germany, in which researchers investigated…
APOE4 gene variant linked to greater nerve damage in MS: Study
A genetic variant strongly linked to Alzheimer’s disease may also worsen neurological damage in people with multiple sclerosis (MS), according to a new study. Researchers found that MS patients carrying the APOE4 variant showed greater signs of neurodegeneration than those without it, including higher levels of nerve damage biomarkers, greater brain tissue damage, and slower…